Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference88 articles.
1. Khosla S, White R, Medina J, Ouwens M, Emmas C, Koder T, et al. Real world evidence (RWE)—a disruptive innovation or the quiet evolution of medical evidence generation? F1000Research. 2018;7.
2. FDA. Framework for FDA’s Real-World Evidence Program. [serial online] 2018 December 2018. https://www.fda.gov/media/120060/download. Accessed 18 June 2019.
3. Berger M, Daniel G, Frank K, Hernandez A, McClellan M, Okun S. A framework for regulatory use of real-world evidence. White paper prepared by the Duke Margolis Center for Health Policy. 2017.
4. Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials. 2015;16:495.
5. Hampson G, Towse A, Dreitlein WB, Henshall C, Pearson SD. Real-world evidence for coverage decisions: opportunities and challenges. J Comp Eff Res. 2018;7(12):1133–43.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献